Roche Gantenerumab gets USFDA Breakthrough Therapy Designation Ruchika Sharma11 Oct 2021 12:15 PM ISTBasel: Roche has recently announced that gantenerumab, an anti-amyloid beta antibody developed for subcutaneous administration, has been granted...
Roche launches cobas pure integrated solutions analyzer in India Ruchika Sharma1 Oct 2021 12:26 PM ISTMumbai: Roche Diagnostics India has recently announced the launch of cobas pure integrated solutions analyzer with a more intelligent system...
Roche antibody cocktail for post-exposure prophylaxis of Covid-19 for adults gets CDSCO panel okay Medical Dialogues Team21 Sept 2021 5:05 PM ISTNew Delhi: With the aim of reducing the spread of the Covid-19 epidemic, the Subject Expert Committee (SEC), functional under the Central Drug...
Roche to acquire TIB Molbiol Group to expand PCR-test portfolio against infectious diseases Ruchika Sharma12 Sept 2021 10:00 AM ISTBasel: Roche has recently announced that the company has signed a definitive share purchase agreement to acquire 100% of the outstanding shares of the...
Roche withdraws Tecentriq for treating type of breast cancer in US Ruchika Sharma28 Aug 2021 10:00 AM ISTNew Delhi: Roche Holding AG has decided to withdraw its immunotherapy Tecentriq as a treatment for a type of breast cancer in the United States, the...
Roche gets USFDA nod for VENTANA MMR RxDx Panel Ruchika Sharma19 Aug 2021 12:45 PM ISTBasel: Roche has recently announced that U.S. Food and Drug Administration (USFDA) has approved the VENTANA MMR RxDx Panel, the first companion...
iSERA Biological begins COVID drug human trials Ruchika Sharma12 Aug 2021 11:00 AM ISTThe results so far have been encouraging, Pratap Deshmukh said, adding the company will be able to deliver the drug at a tenth of the cost charged by...
FIRST: Roche launches Spinal Muscular Atrophy treatment Evrysdi in India Ruchika Sharma30 July 2021 1:30 PM ISTMumbai: Roche has announced the launch of Evrysdi (risdiplam), the first and only approved treatment in India for Spinal Muscular Atrophy (SMA)...
Japanese nod to Ronapreve (casirivimab and imdevimab) for treatment of mild to moderate Covid-19 Ruchika Sharma20 July 2021 10:30 AM ISTBasel: Pharma major, Roche, today announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has approved Ronapreve (casirivimab and...
WHO suggests Roche, Sanofi arthritis drugs to cut death risk in COVID patients Farhat Nasim8 July 2021 12:30 PM ISTA WHO group evaluating therapies concluded treating severe and critical COVID patients with arthritis drugs Actemra from Roche and Kevzara from Sanofi...
Novartis moves court against Roche seeking Rs 1565 crore overpaid amount in patent licensing pact Medical Dialogues Team1 July 2021 5:23 PM ISTNew Delhi: Accusing Roche of illegally pocketing fee from a 16-year-old patent licensing contract, Novartis has filed a lawsuit in U.S. District Court...
Roche gets USFDA EUA for Actemra to treat Covid19 Ruchika Sharma27 Jun 2021 10:00 AM ISTBasel: Roche has recently announced that the U.S. Food and Drug Administration (USFDA) has issued an Emergency Use Authorization (EUA) for intravenous...
